Evidence map›Paper›PMID 17363767›Full record

Trial reportAmerican journal of respiratory and critical care medicine2007

Genetic determinants of emphysema distribution in the national emphysema treatment trial.

Dawn L DeMeo, Craig P Hersh, Eric A Hoffman, Augusto A Litonjua, Ross Lazarus, David Sparrow, Joshua O Benditt, Gerard Criner, Barry Make, Fernando J Martinez and 5 more

Open access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in American journal of respiratory and critical care medicine, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 1 pooled it
15.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 1 synthesis or guideline pooled it, 147 citations in OpenAlex.

  1. Pooled it
  2. Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema.American journal of respiratory and critical care medicine · 2011
    Trial
  3. Trial
  4. Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision.American journal of respiratory and critical care medicine · 2022
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Influence of Emphysema and Air Trapping Heterogeneity on Pulmonary Function in Patients with COPD.International journal of chronic obstructive pulmonary disease · 2019
    Article
  15. Article
  16. Genome-Wide Association Study of the Genetic Determinants of Emphysema Distribution.American journal of respiratory and critical care medicine · 2017
    Article
  17. Article
  18. A Genome-Wide Association Study of Emphysema and Airway Quantitative Imaging Phenotypes.American journal of respiratory and critical care medicine · 2015
    Article
  19. Article
  20. Clinically relevant subgroups in COPD and asthma.European respiratory review : an official journal of the European Respiratory Society · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 1 country.

Dawn L DeMeoChanning Laboratory, Pulmonary and Critical Care Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. dawn.demeo@channing.harvard.edu
Craig P Hersh
Eric A Hoffman
Augusto A Litonjua
Ross Lazarus
David Sparrow
Joshua O Benditt
Gerard Criner
Barry Make
Fernando J Martinez
Paul D Scanlon
Frank C Sciurba
James P Utz
John J Reilly
Edwin K Silverman
Brigham and Women's Hospital · USMayo Clinic · USBoston Medical Center · USNational Jewish Health · USTemple University · USUniversity of Iowa · USUniversity of Michigan · USUniversity of Pittsburgh · USUniversity of Washington · US

Funding

Fine Mapping of COPD Susceptibility GenesR01HL075478 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2004 to 2012
$6.4M
Genetics of COPD in NETTR01HL071393 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2002 to 2005
$1.5M
CLINICAL COORDINATING CENTER FOR LVRS-N01HR76119-268076119-268076119N01HR076119 · HR · JOHNS HOPKINS UNIVERSITY · PI PIANTADOSI, STEVEN · 1997 to 2006
$871k
Asthma Candidate Genes in Alpha 1-Antitrypsin DeficiencyK08HL072918 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI DEMEO, DAWN L · 2003 to 2007
$670k
LUNG VOLUME REDUCTION SURGERY--CLINICAL CENTERN01HR076118 · HR · UNIVERSITY OF WASHINGTON · PI ALBERT, RICHARD K · 1997 to 2000
$225k
LUNG VOLUME REDUCTION SURGERY--CLINICAL CENTERN01HR076113 · HR · UNIVERSITY OF PENNSYLVANIA · PI KAISER, LARRY · 1997 to 2000
$208k
CLNICAL CENTER FOR LVRSN01HR076104 · HR · CEDARS-SINAI MEDICAL CENTER · PI MCKENNA, RICHARD · 1997 to 2000
$153k
CLNICAL CENTER FOR THE LVRSN01HR076102 · HR · BRIGHAM AND WOMEN'S HOSPITAL · PI REILLY, JOHN J · 1997 to 2000
$150k
CLINICAL CENTER FOR LVRSN01HR076114 · HR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KEENAN, ROBERT J · 1997 to 2000
$147k
LUNG VOLUME REDUCTION SURGERY--CLINICAL CENTERN01HR076110 · HR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FERNANDO, MARTINEZ J · 1997 to 2000
$146k
LUNG VOLUME REDUCTION SURGERY--CLINICAL CENTERN01HR076111 · HR · NATIONAL JEWISH HEALTH · PI CHERNIACK, REUBEN M · 1997 to 2000
$144k
CLINICAL CENTER FOR THE LUNG VOLUME REDUCTION SURGERYN01HR076106 · HR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBURG, MARK E · 1997 to 2000
$143k
NHLBI NIH HHS K08 HL072918NHLBI NIH HHS N01HR76101NHLBI NIH HHS N01HR76102NHLBI NIH HHS N01HR76103NHLBI NIH HHS N01HR76104NHLBI NIH HHS N01HR76105NHLBI NIH HHS N01HR76106NHLBI NIH HHS N01HR76107NHLBI NIH HHS N01HR76108NHLBI NIH HHS N01HR76109NHLBI NIH HHS N01HR76110NHLBI NIH HHS N01HR76111NHLBI NIH HHS N01HR76112NHLBI NIH HHS N01HR76113NHLBI NIH HHS N01HR76114NHLBI NIH HHS N01HR76115NHLBI NIH HHS N01HR76116NHLBI NIH HHS N01HR76118NHLBI NIH HHS N01HR76119NHLBI NIH HHS R01 HL075478NHLBI NIH HHS R01 HL71393
6 · The paper itself

Abstract

rationaleComputed tomography (CT) scanning of the lung may reduce phenotypic heterogeneity in defining subjects with chronic obstructive pulmonary disease (COPD), and allow identification of genetic determinants of emphysema severity and distribution.

objectivesWe sought to identify genes associated with CT scan distribution of emphysema in individuals without alpha1-antitrypsin deficiency but with severe COPD.

methodsWe evaluated baseline CT densitometry phenotypes in 282 individuals with emphysema enrolled in the Genetics Ancillary Study of the National Emphysema Treatment Trial, and used regression models to identify genetic variants associated with emphysema distribution. MEASUREMENTS AND MAIN

resultsEmphysema distribution was assessed by two methods--assessment by radiologists and by computerized density mask quantitation, using a threshold of -950 Hounsfield units. A total of 77 polymorphisms in 20 candidate genes were analyzed for association with distribution of emphysema. GSTP1, EPHX1, and MMP1 polymorphisms were associated with the densitometric, apical-predominant distribution of emphysema (p value range = 0.001-0.050). When an apical-predominant phenotype was defined by the radiologist scoring method, GSTP1 and EPHX1 single-nucleotide polymorphisms were found to be significantly associated. In a case-control analysis of COPD susceptibility limited to cases with densitometric upper-lobe-predominant cases, the EPHX1 His139Arg single-nucleotide polymorphism was associated with COPD (p = 0.005).

conclusionsApical and basal emphysematous destruction appears to be influenced by different genes. Polymorphisms in the xenobiotic enzymes, GSTP1 and EPHX1, are associated with apical-predominant emphysema. Altered detoxification of cigarette smoke metabolites may contribute to emphysema distribution, and these findings may lead to further insight into genetic determinants of emphysema.

Indexed as

Polymorphism, Single NucleotideAbsorptiometry, PhotonAgedCase-Control StudiesCohort StudiesEmphysemaEpoxide HydrolasesFemaleGenetic Predisposition to DiseaseGlutathione S-Transferase piHumansMaleMiddle AgedPhenotypePulmonary Disease, Chronic ObstructiveSmokingEPHX1 protein, humanEpoxide HydrolasesGlutathione S-Transferase pi

Identifiers

PMID17363767
PMCPMC2049064
OpenAlexW2015867310

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.